These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8107950)

  • 1. Verotoxin-binding in human renal sections.
    Lingwood CA
    Nephron; 1994; 66(1):21-8. PubMed ID: 8107950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology.
    Lingwood CA
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):375-86. PubMed ID: 10571026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verotoxin receptor glycolipid in human renal tissue.
    Boyd B; Lingwood C
    Nephron; 1989; 51(2):207-10. PubMed ID: 2644572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
    Kiarash A; Boyd B; Lingwood CA
    J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Verotoxin induced hemolytic uremic syndrome: pathophysiology of neurological involvement].
    Takagi C; Naruse T
    Nihon Rinsho; 1997 Mar; 55(3):731-5. PubMed ID: 9086789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit.
    Lingwood CA; Yiu SK
    Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):25-6. PubMed ID: 1314564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent cooperativity in multivalent verotoxin-globotriaosyl ceramide binding: kinetic and saturation binding studies with [(125)I]verotoxin.
    Peter MG; Lingwood CA
    Biochim Biophys Acta; 2000 Jun; 1501(2-3):116-24. PubMed ID: 10838185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives.
    Stenger KO; Windler F; Karch H; von Wulffen H; Heesemann J
    Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome.
    Arbus GS
    Kidney Int Suppl; 1997 Mar; 58():S91-6. PubMed ID: 9067954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
    van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW
    Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms.
    Van Setten PA; van Hinsbergh VW; Van den Heuvel LP; van der Velden TJ; van de Kar NC; Krebbers RJ; Karmali MA; Monnens LA
    J Am Soc Nephrol; 1997 Dec; 8(12):1877-88. PubMed ID: 9402090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody.
    Chark D; Nutikka A; Trusevych N; Kuzmina J; Lingwood C
    Eur J Biochem; 2004 Jan; 271(2):405-17. PubMed ID: 14717708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verotoxin/globotriaosyl ceramide recognition: angiopathy, angiogenesis and antineoplasia.
    Lingwood CA
    Biosci Rep; 1999 Oct; 19(5):345-54. PubMed ID: 10763802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemolytic uremic syndrome].
    Arai T; Matsuzaki K
    Nihon Rinsho; 1996 Sep; 54(9):2551-60. PubMed ID: 8890593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
    Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
    Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome.
    Armstrong GD; Rowe PC; Goodyer P; Orrbine E; Klassen TP; Wells G; MacKenzie A; Lior H; Blanchard C; Auclair F
    J Infect Dis; 1995 Apr; 171(4):1042-5. PubMed ID: 7706786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology.
    Khan F; Proulx F; Lingwood CA
    Kidney Int; 2009 Jun; 75(11):1209-1216. PubMed ID: 19212418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary tubular impairment by verocytotoxin in hemolytic uremic syndrome].
    Uchida H; Fujimoto J; Takeda T
    Nihon Rinsho; 1997 Mar; 55(3):726-30. PubMed ID: 9086788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3).
    Nyholm PG; Brunton JL; Lingwood CA
    Int J Biol Macromol; 1995 Jun; 17(3-4):199-204. PubMed ID: 7577818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias.
    Arab S; Russel E; Chapman WB; Rosen B; Lingwood CA
    Oncol Res; 1997; 9(10):553-63. PubMed ID: 9507533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.